Clinical trials are scientific studies in which new treatments – drugs, diagnostic procedures, and other therapies – are tested to determine if they are safe and effective for patients. Nearly all cancer drugs in use today were tested and made available to patients through clinical trials, making them a crucial component of cancer research.
But what does it mean for a patient to enroll in a clinical trial? In this episode of Cancer Mythbusters, we break down common myths and questions about how these trials work with the help of Geoffrey Shapiro, MD, PhD, director of the Early Drug Development Center at Dana-Farber.
Hear the discussion by listening to the podcast episode below, or click “download” to listen later. Subscribe options are also available via iTunes, Google Play, the Stitcher app, TuneIn app, and RSS.
In the Cancer Mythbusters podcast series, we dive into the many myths and misconceptions in the world of cancer. Every episode, we look at a myth and debunk it with the help of our world-leading clinicians and researchers. Visit Dana-Farber’s podcast page for more information on other cancer podcast series.